Top compounds associated with response to CLEC2L


Feature Type Standardized
Nominal ANOVA
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA 968 CTRPv2 pan-cancer AAC 0.16 0.02
mRNA Pazopanib GDSC1000 pan-cancer AAC 0.081 0.02
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.072 0.02
mRNA TAE684 CCLE pan-cancer AAC 0.1 0.02
mRNA FK866 GDSC1000 pan-cancer AAC -0.069 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.11 0.02
mRNA CUDC-101 GDSC1000 pan-cancer AAC -0.069 0.02
Download CSV